Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Parkinsonism”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableLooking for participantsNCT04179695
What this trial is testing

Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care

Who this might be right for
Parkinson's Disease
University Hospital, Lille 120
Not applicableStudy completedNCT03516994
What this trial is testing

Reducing Disparities in the Quality of Advance Care Planning for Older Adults

Who this might be right for
Metastatic CancerCongestive Heart FailureChronic Obstructive Pulmonary Disease+6 more
Duke University 790
Early research (Phase 1)Study completedNCT02618941
What this trial is testing

Follow-up Study to Assess a Second Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008AA)

Who this might be right for
Parkinson's Disease
Affiris AG 26
Not applicableUnknownNCT02361255
What this trial is testing

Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism

Who this might be right for
Secondary ParkinsonismParkinson's Disease
Corporal Michael J. Crescenz VA Medical Center 40
Not applicableStudy completedNCT00311532
What this trial is testing

Observational Study of Pergolide Mesylate and Cardiac Valvulopathy

Who this might be right for
Parkinson Disease
Eli Lilly and Company 200
Not applicableUnknownNCT02588924
What this trial is testing

Study on the Relationship Between Environmental and Occupational Exposure to Metals and Parkinson's Disease

Who this might be right for
Parkinson Disease, Secondary
University of Campania Luigi Vanvitelli 100
Testing effectiveness (Phase 2)Study completedNCT06671938
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

Who this might be right for
Parkinson DiseaseMultiple System Atrophy
BioArctic AB 38
Not applicableStudy completedNCT06080399
What this trial is testing

Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 70
Post-approval studies (Phase 4)Study completedNCT01733199
What this trial is testing

Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles

Who this might be right for
Parkinson's DiseaseSecondary Behavioural Addiction
Nantes University Hospital 225
Testing effectiveness (Phase 2)Active Not RecruitingNCT04386317
What this trial is testing

Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson's DiseaseSymptomatic Parkinson Disease
Cedars-Sinai Medical Center 15
Not applicableNot Yet RecruitingNCT05072015
What this trial is testing

Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)

Who this might be right for
Parkinson's Disease
University Hospital, Strasbourg, France 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT03775096
What this trial is testing

Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson DiseaseSymptomatic Parkinson Disease
Michele Tagliati, MD 15
Testing effectiveness (Phase 2)Study completedNCT00761137
What this trial is testing

Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients

Who this might be right for
Sialorrhea Secondary to Parkinson's Disease
NeuroHealing Pharmaceuticals Inc. 19
Not applicableLooking for participantsNCT07568067
What this trial is testing

Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome

Who this might be right for
Parkinson DiseaseParkinson Disease, Secondary
Ke Dong, MD 60
Not applicableStudy completedNCT05273957
What this trial is testing

A Model of Hospital-Territory Management Coordinated by a Case Manager to Improve the Care of Patients With Parkinsonism.

Who this might be right for
Parkinson DiseaseAtypical ParkinsonismSecondary Parkinsonism+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 121
Not applicableStudy completedNCT04340492
What this trial is testing

Education for Adapted Physical Activity in Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Lille 89
Not applicableEnded earlyNCT01886131
What this trial is testing

Motor Control During Rapid Eye Movement (REM) Sleep Behaviour Disorder

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05109364
What this trial is testing

Terazosin and Parkinson's Disease Extension Study

Who this might be right for
Symptomatic Parkinson DiseaseREM Sleep Behavior DisorderPre-motor Parkinson's Disease
Cedars-Sinai Medical Center 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04218968
What this trial is testing

Cardiac Changes in Early Parkinson's Disease: A Follow up Study

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson DiseaseSymptomatic Parkinson Disease
Cedars-Sinai Medical Center 15
Not applicableStudy completedNCT05388526
What this trial is testing

Frailty and Cognitive Function in Parkinson's Disease.

Who this might be right for
Parkinson Disease
University of Oviedo 100
Next Page